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SHORT REPORT Open Access
CSF inflammatory markers differ in gram-
positive versus gram-negative shunt
infections
Gwenn L. Skar1* , David Synhorst2, Matthew Beaver1 and Jessica N. Snowden3
Abstract
Background: Cerebrospinal fluid (CSF) shunt placement is frequently complicated by bacterial infection. Shunt
infection diagnosis relies on bacterial culture of CSF which can often produce false-negative results. Negative cultures
present a conundrum for physicians as they are left to rely on other CSF indices, which can be unremarkable. New
methods are needed to swiftly and accurately diagnose shunt infections. CSF chemokines and cytokines may prove
useful as diagnostic biomarkers. The objective of this study was to evaluate the potential of systemic and CSF
biomarkers for identification of CSF shunt infection.
Methods: We conducted a retrospective chart review of children with culture-confirmed CSF shunt infection at Children’s
Hospital and Medical Center from July 2013 to December 2015. CSF cytokine analysis was performed for those patients
with CSF in frozen storage from the same sample that was used for diagnostic culture.
Results: A total of 12 infections were included in this study. Patients with shunt infection had a median C-reactive protein
(CRP) of 18.25mg/dL. Median peripheral white blood cell count was 15.53 × 103 cells/mL. Those with shunt infection had
a median CSF WBC of 332 cells/mL, median CSF protein level of 406mg/dL, and median CSF glucose of 35.5mg/dL. An
interesting trend was observed with gram-positive infections having higher levels of the anti-inflammatory cytokine
interleukin (IL)-10 as well as IL-17A and vascular endothelial growth factor (VEGF) compared to gram-negative infections,
although these differences did not reach statistical significance. Conversely, gram-negative infections displayed higher
levels of the pro-inflammatory cytokines IL-1β, fractalkine (CX3CL1), chemokine ligand 2 (CCL2), and chemokine ligand 3
(CCL3), although again these were not significantly different. CSF from gram-positive and gram-negative shunt infections
had similar levels of interferon gamma (INF-γ), tumor necrosis factor alpha (TNF-α), IL-6, and IL-8.
Conclusions: This pilot study is the first to characterize the CSF cytokine profile in patients with CSF shunt infection and
supports the distinction of chemokine and cytokine profiles between gram-negative and gram-positive infections.
Additionally, it demonstrates the potential of CSF chemokines and cytokines as biomarkers for the diagnosis of shunt
infection.
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Background
Cerebrospinal fluid (CSF) shunts are the most common
treatment of hydrocephalus in the USA; however, they
are frequently complicated by bacterial infection [1].
Shunt infections are responsible for approximately 2400
admissions and 59,000 hospital days annually in the
USA [2]. Bacteria cause the majority of shunt infections,
with Staphylococcus epidermidis and Staphylococcus aur-
eus among the leading causes [3–6]. Apart from
staphylococci, Propionibacterium acnes, enterococci, and
a variety of gram-negative bacteria including Pseudo-
monas aeruginosa and Escherichia coli commonly cause
shunt infections [3–7].
Shunt infections present unique diagnostic and treat-
ment challenges, since they are biofilm rather than
planktonic infections [8]. Bacteria adhere to the catheter
and form a biofilm, communities of bacteria which are
tolerant to antibiotics and actively avoid immune clear-
ance [9]. Thus, the inflammatory response to biofilm in-
fection is distinct from planktonic infection, such as
bacterial meningitis or intracranial abscess [9–12]. Due
to their biofilm nature, shunt infection treatment re-
quires both removal of the infected shunt and days or
weeks of intravenous antibiotics [13]. With the extensive
nature of treatment, it is essential that shunt infections
are diagnosed accurately and rapidly.
While newer DNA-based detection methods are being
instituted in the clinical microbiology laboratory, the
gold standard method to diagnose shunt infection cur-
rently relies on isolating a pathogen from CSF culture
[13–19]. While DNA sequencing methods for microbio-
logical diagnosis are promising, they also have pitfalls,
particularly in the case of shunt infection where many
sequenced pathogens are common skin flora. The utility
of broad-range polymerase chain reaction (PCR) may be
limited by contamination with skin flora during collec-
tion and handling as well as antibiotic administration be-
fore a diagnosis is made [16]. The only multiplex PCR
panel that is currently commercially available for menin-
gitis/encephalitis has a limited spectrum of bacterial or-
ganisms, which is too narrow to be diagnostically useful
for cerebrospinal fluid shunt infections, where Staphylo-
coccus epidermidis and Staphylococcus aureus are the
predominant organisms that are not included in this
panel [3–6].
Traditional CSF culture normally requires 24–48 h to
isolate organisms, and some slower growing organisms
may require several days of incubation, which can delay
appropriate treatment [20]. Additionally, if the patient
has received antibiotics prior to the CSF culture, the cul-
ture may be falsely negative. In these cases, a clinician
must rely on CSF indices such as cell count and differ-
ential, glucose, protein levels, and Gram stain, as well as
clinical presentation, to determine if an infection is
present [19]. A better modality to accelerate and accur-
ately diagnose CSF shunt infections would improve our
ability to treat these infections.
Identifying biomarkers in the CSF or serum of patients
with shunt infection may improve our ability to diagnose
CSF shunt infections. Biomarkers are distinct biochem-
ical, genetic, or molecular substances that characterize
infection [20, 21]. There are a few small studies that
have evaluated the ability of CSF chemokines and cyto-
kines to characterize different bacterial and viral menin-
gitis. Many studies have examined the utility of using
chemokines and cytokines for the diagnosis of meningi-
tis. In early meningeal infection, the pro-inflammatory
cytokines interleukin (IL)-8, IL-1, tumor necrosis factor
alpha (TNF-α), and IL-6 have been shown to be elevated
[22–25]. These mediators are released from CNS resi-
dent cells and function to recruit neutrophils and per-
petuate the inflammatory response [26, 27]. Once
monocytes are recruited, the anti-inflammatory cytokine
IL-10 and IL-1β dampen inflammation by inhibiting pro-
duction of pro-inflammatory cytokines [28].
Several studies have examined the possibility of using
chemokines and cytokines as biomarkers for meningitis
in the pediatric population. Elevated IL-8, IL-1β, TNF-α,
and IL-6 have routinely been shown to be elevated in
bacterial meningitis [23–25, 29, 30]. Another study re-
vealed that cytokines could be used to discriminate be-
tween meningitis caused by Streptococcus pneumoniae,
Neiserria meningitidis, and Haemophilus influenzae
based on levels of interferon gamma (IFN-γ), monocyte
chemoattractant protein-1 (MCP-1), and the enzyme
matrix metallopeptidase-9 (MMP-9) [31].
Studies by Srinivasan et al. [25] in neonates with men-
ingitis have investigated the utility of cytokines as diag-
nostic markers in this population. They found that
TNF-α, IL-1, IL-6, IL-8, IL-10, and IL-12 levels were sig-
nificantly elevated in infants with bacterial meningitis.
However, none of these cytokines were considered suffi-
ciently accurate for a differential diagnosis, which led to
the examination of IL-23, IL-18, and soluble receptor for
advanced glycation end products (sRAGE) in the same
population [32]. The authors concluded that IL-23 might
be a valuable biomarker for the diagnosis of neonatal
bacterial meningitis and, when combined with IL-18 and
sRAGE, diagnosed meningitis with 100% sensitivity and
specificity [32]. Interestingly, relevant to the current re-
port, of the 11 neonates with confirmed meningitis in
these studies, there were 4 patients with ventriculoperi-
toneal shunts in place [25, 32].
To date, no study has examined CSF chemokine and
cytokine expression exclusively in patients with CSF
shunt infections. Animal models of shunt infection sug-
gest that the inflammatory response in these biofilm in-
fections may be attenuated in comparison to planktonic
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infections; thus, by extension, the same cytokine and
chemokine responses may not be observed in shunt in-
fections as in meningitis [9, 10, 33–35]. One study of
shunt infection identified a possible role for soluble
membrane attack complex in diagnosis of shunt infec-
tion, but this molecule was not able to identify many
cases of S. epidermidis infection, which is the most com-
mon cause of shunt infection [36]. Therefore, to
characterize potential biomarkers of CSF shunt infection,
we evaluated systemic indicators of infection as well as
CSF cytokines in a cohort of patients diagnosed with
CSF shunt infection.
Methods
In this retrospective study, we included all patients less
than or equal to 21 years of age with culture-confirmed
bacterial CSF shunt infection diagnosed between July 1,
2013, and December 31, 2015, at Children’s Hospital and
Medical Center (CHMC) in Omaha, Nebraska. Patients
were identified by International Classification of Disease,
9th revision coding, and confirmed by positive CSF cul-
ture results in accordance with the modified criteria for
nosocomial infection of the US Centers for Disease Con-
trol and Prevention [15]. CSF culture was performed in
the clinical microbiology laboratory at CHMC in accord-
ance with the Clinical Microbiology Procedure Hand-
book [17]. CSF cell count, differential, glucose, and
protein levels were assessed in the clinical laboratory at
CHMC in accordance with Clinical & Laboratory Stan-
dards Institute protocols [37, 38].
Patients were excluded if their diagnostic CSF culture
was performed at another institution or grew yeast or if
no CSF culture data was available. All participants were
screened for additional inflammatory infection by med-
ical chart review and were excluded if there was an add-
itional inflammatory condition documented in the
medical record that would alter inflammatory markers,
such as a concomitant viral upper respiratory infection.
Data extracted from the patients’ chart included the
following: patient age, peripheral white blood cell
(WBC) count, peripheral C reactive-protein (CRP), CSF
WBC count and differential, CSF glucose, CSF protein,
and CSF culture results. Patient’s peripheral WBC, CRP,
CSF WBC and differential, CSF glucose, and CSF protein
were included if they were obtained within a 48-h win-
dow from the time of the CSF culture.
For those patients with CSF in frozen storage from the
same sample that was used for diagnostic culture, add-
itional cytokine analysis was conducted. The CSF was
analyzed by multiplex analysis for cytokines and chemo-
kines (Millipore Milliplex Billerica, MA). The multiplex
panels included the following: chemokine ligand 2
(CCL2), chemokine ligand 3 (CCL3), fractalkine
(CX3CL1), vascular endothelial growth factor (VEGF),
TNF-α, IFN-γ, IL-1β, IL-6, IL-8, IL-10, and IL-17A.
Descriptive statistics were performed using SigmaPlot.
A t test was used to compare mean cytokine levels in
those patients with gram-positive shunt infection com-
pared to those with gram-negative infection. This study
was approved by the University of Nebraska Medical
Center Institutional Review Board.
Results
A total of 11 individual patients with 12 separate shunt
infections were included in this study (Table 1). Patient
ages ranged from 5 weeks to 20 years with a median age
of 4 months. All patients had a culture-confirmed ventri-
culoperitoneal shunt infection. Organisms identified
from culture included the following: methicillin-resistant
Staphylococcus aureus (1), viridans group streptococci
(1), coagulase-negative staphylococci (2), Enterococcus
faecalis (1), Gemella haemolysans (1), Serratia marces-
cens (1), Pseudomonas aeruginosa (2), Escherichia coli
(1), Enterobacter cloacae (1), and Stenotrophomonas
maltophilia (1).
Of the eight patients with CRP, the median was 18.25
mg/dL (0.5–35.9 mg/dL). All but one patient had a per-
ipheral WBC count performed within 48 h of their CSF
culture, and the median WBC was 15.53 × 103 cells/mL
(5.97–29.71 × 103 cells/mL). Nine patients had CSF
WBC within 48 h of their CSF culture with a median
CSF WBC of 332 cells/mL (24–1914 cells/mL). The
gram-positive infections appeared to have a neutrophil
predominance in the CSF while gram-negative infections
had a more varied cellular differential. Eight patients had
results for CSF protein and CSF glucose. CSF protein
had a median value of 406 mg/dL (24–600 mg/dL), and
CSF glucose had a median value of 35.5 mg/dL (20–75
mg/dL).
Seven of the patients had CSF available for cytokine
analysis; of these, three had gram-positive infections and
four had gram-negative. While not statistically signifi-
cant, an interesting trend was observed with CSF from
patients with gram-positive infections having higher
levels of the anti-inflammatory cytokine IL-10 (1321.17
pg/mL vs 514.49 pg/mL) as well as IL-17A (193.95 pg/
mL vs 14.05 pg/mL) and VEGF (303.84 pg/mL vs 45.37
pg/mL) (Fig. 1). In contrast, the gram-negative group
had increases in IL-1β (1522.76 pg/mL vs 179.79 pg/mL)
and numerous chemokines, including CX3CL1 (532.93
pg/mL vs 187.95 pg/mL), CCL2 (7094.50 pg/mL vs
5741.00 pg/mL), and CCL3 (665.74 pg/mL vs 183.06 pg/
mL) (Fig. 1). Levels of IFN-γ (39.06 pg/mL vs 50.75 pg/
mL), TNF-α (184.14 pg/mL vs 215.41 pg/mL), IL-6
(5191.26 pg/mL vs 4816.35 pg/mL), and IL-8 (3390.38
pg/mL vs 2687.22 pg/mL) were similar in both
gram-negative and gram-positive infections (Fig. 1).
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Discussion
Prompt diagnosis of shunt infection can allow for earlier
treatment, including surgical intervention, potentially
averting damaging consequences such as seizures and
reduced IQ [39, 40]. However, CSF cultures may be
negative due to prior antibiotic treatment or the diffi-
culty of traditional culture in detecting biofilm infec-
tions. In these settings, clinicians are forced to use CSF
indices and peripheral markers of inflammation to diag-
nose shunt infection. As observed in our cohort, periph-
eral leukocytosis is not always present in shunt infection
and is very non-specific. CRP elevation was noted in our
cohort and in others, but this has been inconsistent in
other case studies [20, 21, 41]. CSF leukocytosis is a
more specific measure for CSF infection and was ob-
served in this group of patients. However, this can also
occur in the setting of uninfected post-surgical inflam-
mation, which presents a significant confounder as the
post-surgical period is also the highest risk for shunt in-
fection [42]. CSF protein was elevated in our cohort; un-
fortunately, prior studies have shown that CSF protein
levels cannot distinguish aseptic post-surgical inflamma-
tion from shunt infection [42]. While hypoglycorrhachia
occurred in our patients, this is again unable to differen-
tiate post-surgical chemical meningitis from shunt infec-
tion [42]. In this population where infection most
commonly occurs within 30 days of surgery, it is crucial
to be able to differentiate post-surgical inflammation
from shunt infection. Identification of more specific
markers of infection is essential to improve our ability to
identify these infections.
Pro-inflammatory mediators have been explored as a
diagnostic strategy for bacterial meningitis. Multiple
studies have demonstrated elevated levels of TNF-α,
IL-6, and IL-8 in the CSF of patients with bacterial men-
ingitis, especially in the pediatric population [22–25, 29,
30]. While there is promising data for TNF-α, IL-6, and
IL-8 as diagnostic biomarkers in meningitis, CSF shunt
infections are a biofilm rather than planktonic infection
which skews the host immune response [10, 12]. There-
fore, we examined cytokine/chemokine expression in the
CSF of patients with gram-positive and gram-negative
shunt infection.
The results of our study demonstrated similar levels of
INF-γ, TNF-α, IL-6, and IL-8 in the CSF of patients with
both gram-positive and gram-negative CSF shunt infec-
tions. This is consistent with results from Srinivasan et
al. [25], which demonstrated elevated levels of these me-
diators in neonates with meningitis, 36% percent of
which had a shunt infection. Our data as well as mul-
tiple studies in pediatric meningitis demonstrate that
TNF-α, IL-6, and IL-8 are present in the CSF of patients
with neurologic infection; however, these are likely not
good markers for differentiating shunt infection from
meningitis [24, 25, 30].
In our cohort, there were trends of a distinct inflammatory
response in gram-positive versus gram-negative shunt infec-
tions. CSF from patients with gram-positive infections had
Table 1 Patient age, CSF parameters, and CSF culture results
Patient
number
Age
(months)
CRP
(mg/
dL)
Peripheral
WBC
(cells/mL)
CSF
WBC
(cells/
mL)
CSF WBC
differential
(percentage)
CSF protein
(mg/dL)
CSF glucose
(mg/dL)
CSF culture result Cytokine analysis
performed
N L M O
1 36 35.9 17.33 NA NA NA NA Methicillin-resistant
Staphylococcus aureus
No
2 5 NA 18.26 NA NA NA NA Viridans group streptococci No
3 8 5.1 9.63 1575 98 0 1 0 166 20 Gemella haemolysans No
4 3 17.4 8.54 985 99 1 0 0 600 21 Coagulase-negative
staphylococci
Yes
5 24 NA NA 47 69 18 13 0 114 67 Coagulase-negative
staphylococci
Yes
6 240 8.9 29.71 377 86 6 8 0 600 75 Enterococcus faecalis Yes
7 1.25 NA 12.2 NA NA NA Enterobacter cloacae No
7 3 NA 27.57 212 8 52 40 0 NA NA Serratia marcescens No
8 3 0.5 13.33 332 26 31 43 0 212 23 Pseudomonas aeruginosa Yes*
9 3 19.1 15.57 1914 80 1 10 9 600 20 Pseudomonas aeruginosa Yes
10 84 27 12.73 24 8 21 68 3 24 61 Stenotrophomonas maltophilia Yes*
11 5 19.9 5.97 28 79 13 6 2 600 48 Escherichia coli Yes
CRP C-reactive protein, WBC white blood cell count, CSF cerebrospinal fluid, N neutrophils, L lymphocytes, M monocytes, O other cell type, NA data not available
*Not included in analysis for IFN-γ of IL-17A
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higher levels of the anti-inflammatory cytokine IL-10 as well
as IL-17A and VEGF. Those with gram-negative infection
had higher levels of the pro-inflammatory cytokines IL-1β,
CX3CL1 CCL2, and CCL3.
The increase in IL-10 in the gram-positive patients is
consistent with a murine model of S. epidermidis CNS
catheter infection [34]. This study demonstrated elevated
levels of IL-10 in mice with S. epidermidis infected
A B
C D
E F
G H
I
K
J
Fig. 1 CSF from patients with gram-positive infection has elevated levels of IL-10 (a), IL-17A (b), and VEGF (c) compared to gram-negative
infections. Gram-negative shunt infections demonstrate increases in IL-1β (d), Cx3CL1 (E), CCL2 (f), and CCL3 (g). Gram-positive and gram-negative
infections resulted in nearly equivalent levels of INF-γ (h), TNF-α (i), IL-6 (j), and IL-8 (k). n = 3 patients in gram-positive group, n = 2–4 gram-
negative group (2 samples had sufficient quantity for measurement of IFN-γ and IL-17A)
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compared to sterile catheters [34]. IL-10 is an
anti-inflammatory cytokine essential for controlling the
production of pro-inflammatory cytokines [43, 44]. It is
known to play a role in acute and chronic inflammation
in the CNS, and in the setting of CNS catheter infection,
its presence may curb the inflammatory environment
[34, 45]. Additionally, the presence of IL-10 has been
highly associated with other types of staphylococcal in-
fection. Rose et al. [46] demonstrated patients with ele-
vated levels of IL-10 at the time of presentation with
Staphylococcus aureus blood stream infection had higher
mortality. Interestingly, two of the patients included in
our cytokine analysis cohort had coagulase-negative
staphylococcal infections. The increase in IL-10 may be
dampening pro-inflammatory mediators, such as the ele-
vated IL-17A and VEGF seen in these patients, and serv-
ing a neuroprotective role. This is being further
evaluated in animal models of shunt infection.
In addition to increased IL-10, patients with
gram-positive infections had higher levels of IL-17A and a
neutrophil predominance in the CSF when compared to
patients with gram-negative shunt infection. This is con-
sistent with IL-17’s role as an inducer of neutrophil che-
mokines, including IL-8, and IL-17’s importance in a
murine model of Staphylococcus aureus brain abscess [47,
48]. While shunt infections are biofilm rather than plank-
tonic infections like brain abscess, the increased levels of
IL-17A and neutrophil predominance in the CSF in our
cohort suggest a Th17 response to gram-positive shunt in-
fections in humans may predominate.
In addition to elevated IL-10 and IL-17A, patients with
gram-positive shunt infection had elevated levels of VEGF, a
potent mediator of vascular permeability associated with
cerebral edema and neutrophil migration in the CNS [49–
51]. VEGF has been shown to be elevated in a rabbit model
of Streptococcus pneumoniae meningitis as well as in tuber-
culous meningitis and other types of bacterial meningitis
[52–54]. VEGF may be playing a role in the disruption of the
blood-brain barrier in CNS infections, although it is unclear
why VEGF is higher in patients with gram-positive shunt in-
fection. This will be explored further in future studies.
Our ability to evaluate whether the gram-negative
shunt infections have a Th1, Th2, or Th17 bias was lim-
ited due to sample availability. However, the data would
suggest a potential skewing towards a Th1 immune re-
sponse in gram-negative shunt infection with increased
monocytes in the CSF of these patients compared to
gram-positive infection as well as increase in IL-1β and
a modest increase in INF-γ in gram-negative infection.
While there is limited data on the type of immune re-
sponse gram-negative bacteria create in the CNS, studies
have demonstrated that gram-negative elicit Th1 im-
mune responses in models of intestinal inflammatory
disorders [55, 56].
The CSF patterns reported in this study are likely re-
flective of differing immune pathways triggered by
gram-positive versus gram-negative organisms [23]. Im-
portantly, while chemokine and cytokine profiles have
been evaluated as CSF biomarkers of meningitis, evalu-
ation of these markers in the setting of shunt infection
has been limited [25, 29, 31, 36]. Our results suggest that
the distinct cytokine profiles elicited by gram-positive
and gram-negative pathogens show promise as diagnos-
tic tools for CNS shunt infections.
Conclusions
This pilot study is the first to characterize the CSF cyto-
kine profile in patients with CSF shunt infection and has
revealed distinct chemokine and cytokine profiles between
gram-negative and gram-positive infections. While there
is an interesting trend in the CSF cytokines that could
greatly improve diagnosis of CSF shunt infection, there
are several limitations with this pilot study. Epidemiologi-
cally, coagulase-negative staphylococci is the most com-
mon cause of CSF shunt infection, causing approximately
two thirds of shunt infections, with Staphylococcus aureus
as the second most common cause [4, 5, 33]. In contrast,
this cohort of patients included a broad range of causative
bacteria which did not follow typical epidemiologic pat-
terns. However, our data demonstrate the elevation of
chemokines and cytokines in the CSF of patients with
shunt infection demonstrating the potential of CSF che-
mokine and cytokine measurement serving as a diagnostic
strategy for shunt infection.
Secondly, in this small cohort, which was not large
enough to determine statistical significance, clear trends of
chemokines and cytokines were evident in gram-positive
versus gram-negative shunt infection. These trends demon-
strate a potential Th17-predominant immune response to
gram-positive shunt infection and Th1-predominant re-
sponse in gram-negative shunt infection. Additionally, due
to the restrictions of available CSF, there is not a control
population as CSF is not obtained from the shunts of well
children as there is the possibility of iatrogenic infection.
To address these limitations, we are currently developing a
rat model of CSF shunt infection to further delineate CSF
and serum inflammatory profiles in a controlled manner
that will allow for analysis of postoperative versus infective
changes. However, these pilot findings serve as a valuable
introduction to the potential of CSF chemokines and cyto-
kines as biomarkers for the diagnosis of shunt infection. By
improving our ability to diagnose these infections, we can
provide earlier effective therapy in a disease process which
remains difficult to diagnose and treat.
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